Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Abbott Laboratories (NY: ABT )

109.03 -0.42 (-0.38%)
Streaming Delayed Price Updated: 11:02 AM EDT, Jun 27, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 989,525
Open 109.90
Bid (Size) 109.04 (2)
Ask (Size) 109.07 (1)
Prev. Close 109.45
Today's Range 108.30 - 110.10
52wk Range 101.24 - 142.60
Shares Outstanding 1,750,942,289
Dividend Yield 1.65%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Could This Company's Gastrointestinal Drug Be A Powerful Pill For People And Animals With Chronic, Debilitating Diarrhea?
San Francisco-based Jaguar Health, Inc. (NASDAQ: JAGX), a commercial-stage pharmaceuticals company, says it is focused on developing novel, plant-based, non-opioid and sustainably derived prescription... 
Via Benzinga
Amazon.com To $180? Here's The Biggest Price Target Changes For Friday
Piper Sandler cut Accenture plc (NYSE: ACN) price target from $368 to $305. Accenture shares gained 4.2% to trade at $297.69 on Friday. 
Via Benzinga

Performance

YTD
-21.58%
-21.58%
1 Month
-6.56%
-6.56%
3 Month
-9.13%
-9.13%
6 Month
-22.92%
-22.92%
1 Year
-5.76%
-5.76%

More News

Read More
What 6 Analyst Ratings Have To Say About Abbott Laboratories
Via Benzinga
Here's How Much $1000 Invested In Abbott Laboratories 5 Years Ago Would Be Worth Today
Via Benzinga
ABBOTT LABORATORIES INVESTIGATION ALERT REMINDER: Scott+Scott Attorneys at Law LLP Continues to Investigate Abbott Laboratories’ Directors and Officers for Breach of Fiduciary Duties – ABT
From Scott+Scott Attorneys at Law LLP
Via Business Wire
Abbott Restarts Baby Formula Plant
Via Talk Markets
Benzinga Before The Bell: Tesla's Cybertruck Update, Twitter's New Feature, Netflix's Ad-Tier And Other Top Financial Stories Thursday, June 23
Via Benzinga
FDA Probes Another Infant Death Given Abbott Formula, Less Than Month After Troubled Plant Reopens
Via Benzinga
What It Means For US Stocks To Be In A Bear Market
Via Benzinga
Benzinga Before The Bell: Tesla Raises Prices, Revlon Goes Bankrupt And Other Top Financial Stories Thursday, June 16
Via Benzinga
More Trouble For Baby Formula Production As Thunderstorms, Flood, Hit Abbott's Troubled Michigan Plant
Via Benzinga
As Health Problems Mount Patients Welcome New Treatments
Via FinancialNewsMedia
3 Dividend Stocks to Buy Now for 20 Years of Income Growth
Via InvestorPlace
Relief May Soon Be On The Way For Diabetes Sufferers Weary Of Constant Pin Pricks, According To This Company
Via Benzinga
7 Undervalued Penny Stocks to Buy for Massive Gains
Via InvestorPlace
7 Monkeypox Stocks That May Take Off in Q2
Via InvestorPlace
If You Invested $1000 In This Stock 10 Years Ago, You Would Have $3,900 Today
Via Benzinga
Analyzing Abbott Laboratories's Short Interest
Via Benzinga
5 Analysts Have This to Say About Abbott Laboratories
Via Benzinga
SOBRsafe CEO Reports Boosting Holdings In Company
Via Benzinga
Abbott Stock Looks To Emerge From Bear Market Stronger
Via Investor's Business Daily
Australia, New Zealand Express Support To Address USA Baby Food Crisis
Via Benzinga
INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates Abbott Laboratories’ Directors and Officers for Breach of Fiduciary Duties – ABT
From Scott+Scott Attorneys at Law LLP
Via Business Wire
Dexcom Pops After Insulet Buyout Rumor Shakes Up Diabetes Stocks
Via Investor's Business Daily
$100 Invested In Abbott Laboratories 10 Years Ago Would Be Worth This Much
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.